Sarah Z Rush
Overview
Explore the profile of Sarah Z Rush including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson A, Severson E, Gay L, Vergilio J, Elvin J, Suh J, et al.
Oncologist
. 2017 Sep;
22(12):1478-1490.
PMID: 28912153
Background: Pediatric brain tumors are the leading cause of death for children with cancer in the U.S. Incorporating next-generation sequencing data for both pediatric low-grade (pLGGs) and high-grade gliomas (pHGGs)...
2.
Lindsay A, Rush S, Fenton L
J Neurooncol
. 2014 May;
118(2):395-404.
PMID: 24792487
Ganglioglioma (GG) is a rare pediatric brain tumor (1-4 %) with neoplastic glial and neuronal cells. Posterior fossa GGs (PF GGs) occur less frequently than supratentorial GGs (ST GGs). The...
3.
Donson A, Kleinschmidt-DeMasters B, Aisner D, Bemis L, Birks D, Mulcahy Levy J, et al.
Brain Pathol
. 2013 Nov;
24(2):173-83.
PMID: 24238153
Brainstem gangliogliomas (GGs), often cannot be resected, have a much poorer prognosis than those located in more common supratentorial sites and may benefit from novel therapeutic approaches. Therapeutically targetable BRAF...
4.
Madden J, Rush S, Stence N, Foreman N, Liu A
J Pediatr Hematol Oncol
. 2013 Oct;
36(2):e105-8.
PMID: 24136023
Neurofibromatosis type 1 (NF1) is a genetic disorder that predisposes patients to the formation of sporadic tumors and also increases the risk of radiation-induced malignancies. The most commonly described radiation-induced...
5.
Barton V, Donson A, Birks D, Kleinschmidt-DeMasters B, Handler M, Foreman N, et al.
J Neuropathol Exp Neurol
. 2013 Apr;
72(5):442-9.
PMID: 23584203
Prognostic factors in pilocytic astrocytomas (PAs) and pilomyxoid astrocytomas (PMAs) include extent of resection, location, and age, but no molecular markers have been established. Insulin-like growth factor 2 mRNA binding...
6.
Chan M, Kleinschmidt-DeMasters B, Donson A, Birks D, Foreman N, Rush S
Pediatr Blood Cancer
. 2012 Jun;
59(7):1173-9.
PMID: 22706982
Background: Gangliogliomas (GGs) primary to brainstem are rare, with the overwhelming majority of GGs occurring in supratentorial, especially temporal lobe, locations. A less favorable prognosis exists for brainstem GGs, despite...
7.
Xu B, An Q, Gowda S, Yan W, Pierce L, Abel T, et al.
Int J Oncol
. 2012 Feb;
40(6):1995-2003.
PMID: 22307528
Analyzing molecular biomarkers using blood is an important approach for clinical assessment of malignant glioma. We investigated a molecular proteomic biomarker-based approach for glioblastoma using patients' blood samples. The expression...
8.
Rush S, Abel T, Valadez J, Pearson M, Cooper M
Neuro Oncol
. 2010 Mar;
12(8):790-8.
PMID: 20223881
Pilocytic astrocytoma is commonly viewed as a benign lesion. However, disease onset is most prevalent in the first two decades of life, and children are often left with residual or...